← 產業報告目錄

Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-03-19頁數 610報告編號 MD5241

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The poultry diagnostics market is projected to grow from USD 0.18 billion in 2026 to USD 0.25 billion by 2031, at a CAGR of 7.1%. This growth is driven by several key factors that are shaping the future of poultry disease diagnostics, surveillance, and flock health management. The primary driver of the poultry diagnostics market is the rapid expansion of commercial poultry production worldwide and the increasing demand to control infectious disease outbreaks in large flocks. As poultry farming becomes more intensive, businesses in animal husbandry are adopting early disease detection and regular health monitoring as essential strategies to prevent production losses and ensure the ongoing productivity of their flocks. Consequently, poultry farms, veterinary laboratories, and integrated poultry companies are increasingly using advanced diagnostic methods, such as PCR and ELISA, to quickly and accurately identify pathogens, including avian influenza, Newcastle disease, and infectious bronchitis. Another significant factor driving demand is the heightened focus on biosafety, food security, and the control of regulated diseases throughout the global poultry supply chain. Governments, international organizations, and poultry farmers are enhancing their disease-tracking systems to prepare for major outbreaks that could result in substantial losses in meat and egg production and disrupt international trade. As a result, the use of diagnostics in poultry testing has become a common practice to facilitate safe access to production facilities and enable producers and veterinary authorities to implement timely containment measures while maintaining stable production levels. Moreover, advancements in molecular diagnostics, automation, and mass testing capabilities have significantly improved the accuracy and efficiency of identifying poultry diseases. Innovations such as rapid PCR testing methods, robotic ELISA operations, portable diagnostic kits, and advanced sample processing are reducing response times and enabling large-scale testing of entire flocks. By leveraging these technological advancements, poultry producers and diagnostic laboratories can enhance their disease control strategies, ensuring optimal flock health monitoring and promoting ecological stability within modern poultry farming systems. "By test type, the PCR-based diagnostics segment is projected to grow at the highest CAGR during the forecast period." The PCR-based diagnostics segment is expected to experience the highest growth in the poultry diagnostics market due to its high sensitivity and specificity, as well as its ability to quickly detect pathogens. PCR technology can identify even trace amounts of viral or bacterial genetic material. This capability allows for the detection of poultry diseases, such as avian influenza, Newcastle disease, and infectious bronchitis, at the pre-symptomatic stage, providing a timely opportunity for intervention. Intervening early helps limit the spread and impact of epidemics, reducing production losses. Additionally, the increasing demand for rapid, large-scale testing and improved disease monitoring in intensive poultry production systems is driving the widespread adoption of PCR-based diagnostics on commercial farms and in veterinary diagnostic laboratories. "By sample type, the swabs segment accounted for the largest market share in 2025." In 2025, swabs led the poultry diagnostics market due to their ease of collection, non-invasive nature, and high reliability in detecting poultry pathogens. The two most common types of swab samples collected for diseases such as avian influenza, Newcastle disease, and infectious bronchitis are oropharyngeal and cloacal swabs. These swab samples are often used for disease surveillance and outbreak investigations. Swabs are the preferred sample type on poultry farms, in veterinary laboratories, and in surveillance programs because they are compatible with widely used diagnostic methods such as PCR and ELISA. Additionally, swabs facilitate sample collection from large flocks, making them ideal for large-scale testing and monitoring programs, which explains their extensive use in poultry disease diagnostics. “The Asia Pacific region is expected to witness the highest growth rate during the forecast period.” The Asia Pacific region is experiencing the fastest growth in the poultry diagnostics market. This growth can be attributed to several factors, including the rapid increase in poultry production, higher consumption rates, and the expansion of disease surveillance in major poultry-producing countries such as China, India, and various Southeast Asian nations. The region has faced multiple outbreaks of avian influenza and Newcastle disease, highlighting the importance of early detection and regular flock monitoring. Additionally, improvements in veterinary infrastructure and the rise of government initiatives for disease control and food safety are enabling poultry farms and veterinary laboratories in the region to adopt advanced diagnostic technologies more swiftly. Breakdown of supply-side primary interviews: •By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%) •By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%) •By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Breakdown of demand-side primary interviews: •By End User: Veterinary Diagnostic Laboratories (45%), Integrated Poultry Producers (24%), Government & Reference Laboratories (14%), Academic & Research Institutions (10%), and Other Specialized Laboratories (7%) •By Designation: Heads/Directors of Veterinary Diagnostic Laboratories (47%), Poultry Veterinarians/Technical Services Managers (22%), Animal Health Surveillance Officers (15%), and Others (16%) •By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%) Research Coverage The market study covers the poultry diagnostics market in various segments. It aims to estimate the market size and growth potential by product type, test type, disease type, poultry type, sample type, end user, and region. The study also includes an in-depth competitive analysis of the market's key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below. This report provides insights into the following points: • Analysis of key drivers (rising incidence of transboundary & endemic diseases and growth in commercial & industrial poultry production), restraints (high cost of advanced molecular testing platforms and limited diagnostic infrastructure in developing regions), opportunities (geographic expansion in emerging poultry markets and development of rapid point-of-care (POC) tests), and challenges (rapid mutation and strain variability of viral pathogens and limited awareness among small & backyard farmers) influencing the growth of the poultry diagnostics market. • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the poultry diagnostics market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of poultry diagnostic products across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the poultry diagnostics market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the poultry diagnostics market.
目錄 Table of Contents
1 INTRODUCTION 49 1.1 STUDY OBJECTIVES 49 1.2 MARKET DEFINITION 49 1.3 STUDY SCOPE 49 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 50 1.3.2 INCLUSIONS & EXCLUSIONS 51 1.3.3 YEARS CONSIDERED 52 1.4 MARKET STAKEHOLDERS 53 1.5 SUMMARY OF CHANGES 53 2 EXECUTIVE SUMMARY 55 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 55 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 56 2.3 DISRUPTIVE TRENDS IN POULTRY DIAGNOSTICS MARKET 57 2.4 HIGH-GROWTH SEGMENTS 58 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 59 3 PREMIUM INSIGHTS 60 3.1 POULTRY DIAGNOSTICS MARKET OVERVIEW 60 3.2 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE & COUNTRY (2025) 61 3.3 POULTRY DIAGNOSTICS MARKET: REGIONAL MIX 62 3.4 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63 3.5 POULTRY DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 64 4 MARKET OVERVIEW 65 4.1 INTRODUCTION 65 4.2 MARKET DYNAMICS 65 4.2.1 DRIVERS 66 4.2.1.1 Rising incidence of transboundary and endemic diseases 66 4.2.1.2 Growth in commercial and industrial poultry production 66 4.2.1.3 Shift toward preventive flock health management 67 4.2.1.4 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms 68 4.2.2 RESTRAINTS 68 4.2.2.1 High cost of advanced molecular diagnostic platforms and automated systems 68 4.2.2.2 Limited diagnostic infrastructure in developing regions 69 4.2.3 OPPORTUNITIES 70 4.2.3.1 Geographic expansion in emerging poultry markets 70 4.2.3.2 Expansion of rapid point-of-care and portable on-farm diagnostic solutions 70 4.2.4 CHALLENGES 71 4.2.4.1 Rapid mutation and strain variability of viral pathogens 71 4.2.4.2 Limited awareness among small & backyard farmers 71 4.3 UNMET NEEDS & WHITE SPACES 72 4.3.1 UNMET NEEDS IN POULTRY DIAGNOSTICS MARKET 72 4.3.2 WHITE SPACE OPPORTUNITIES 73 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 73 4.4.1 INTERCONNECTED MARKETS 73 4.4.2 CROSS-SECTOR OPPORTUNITIES 74 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74 5 INDUSTRY TRENDS 75 5.1 PORTER’S FIVE FORCES ANALYSIS 75 5.1.1 THREAT OF NEW ENTRANTS 76 5.1.2 THREAT OF SUBSTITUTES 76 5.1.3 BARGAINING POWER OF SUPPLIERS 76 5.1.4 BARGAINING POWER OF BUYERS 77 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 77 5.2 MACROECONOMIC INDICATORS 77 5.2.1 INTRODUCTION 77 5.2.2 GDP TRENDS & FORECAST 77 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 79 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 79 5.3 SUPPLY CHAIN ANALYSIS 79 5.4 VALUE CHAIN ANALYSIS 81 5.5 ECOSYSTEM ANALYSIS 82 5.6 PRICING ANALYSIS 83 5.6.1 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 83 5.6.2 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025 85 5.6.2.1 Average selling price trend of ELISA kits & reagents, by region, 2023−2025 86 5.6.2.2 Average selling price trend of PCR reagents & kits, by region, 2023−2025 86 5.6.2.3 Average selling price trend of sample preparation & extraction kits, by region, 2023−2025 86 5.6.2.4 Average selling price trend of controls & laboratory consumables, by region, 2023−2025 87 5.6.2.5 Average selling price trend of PCR instruments, by region, 2023−2025 87 5.6.2.6 Average selling price trend of ELISA readers & washers, by region, 2023−2025 87 5.6.2.7 Average selling price trend of nucleic acid extraction systems, by region, 2023−2025 88 5.7 TRADE ANALYSIS 88 5.7.1 TRADE DATA FOR HS CODE 3822 89 5.7.1.1 Import data for HS Code 3822 89 5.7.1.2 Export data for HS Code 3822 89 5.8 KEY CONFERENCES & EVENTS, 2026–2027 90 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91 5.10 INVESTMENT & FUNDING SCENARIO 91 5.11 SUCCESS STORIES & REAL-WORLD APPLICATIONS 92 5.11.1 AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 92 5.11.2 MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR 93 5.11.3 MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS 94 5.12 IMPACT OF 2025 US TARIFFS ON POULTRY DIAGNOSTICS MARKET 94 5.12.1 INTRODUCTION 94 5.12.2 KEY TARIFF RATES 96 5.12.3 PRICE IMPACT ANALYSIS 96 5.12.4 IMPACT ON COUNTRY/REGION 97 5.12.5 IMPACT ON END-USE INDUSTRIES 98 5.12.5.1 Veterinary diagnostic laboratories 98 5.12.5.2 Integrated poultry producers 98 5.12.5.3 Government & reference laboratories 99 5.12.5.4 Academic & research institutions 99 5.12.5.5 Other specialized laboratories 99 6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION 100 6.1 TECHNOLOGY ANALYSIS 100 6.1.1 KEY EMERGING TECHNOLOGIES 100 6.1.1.1 CRISPR-based molecular diagnostics 100 6.1.1.2 Isothermal amplification and paper-based LAMP 100 6.1.2 COMPLEMENTARY TECHNOLOGIES 101 6.1.2.1 Environmental & wastewater surveillance 101 6.1.2.2 Microfluidic sensors 101 6.1.3 ADJACENT TECHNOLOGIES 102 6.1.3.1 AI & machine learning 102 6.1.3.2 Multiplex PCR panels 103   6.2 TECHNOLOGY/PRODUCT ROADMAP 103 6.2.1 NEAR TERM (2025–2027) 103 6.2.2 MID TERM (2028–2030) 104 6.2.3 LONG TERM (2030+) 104 6.3 PATENT ANALYSIS 104 6.3.1 PATENT PUBLICATION TRENDS FOR POULTRY DIAGNOSTICS 104 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 105 6.4 FUTURE APPLICATIONS 107 6.4.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION 107 6.4.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS 108 6.4.3 CONTINUOUS ENVIRONMENTAL & WASTEWATER MONITORING SYSTEMS 108 6.4.4 MULTIPLEX & SYNDROMIC POULTRY DIAGNOSTIC PANELS 108 6.4.5 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING 108 6.5 IMPACT OF AI/GENERATIVE AI ON POULTRY DIAGNOSTICS MARKET 108 6.5.1 INTRODUCTION 108 6.5.2 MARKET POTENTIAL IN POULTRY DIAGNOSTIC ECOSYSTEM 109 6.5.3 AI USE CASES 109 6.5.4 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET 110 7 SUSTAINABILITY & REGULATORY LANDSCAPE 111 7.1 REGIONAL REGULATIONS & COMPLIANCE 111 7.1.1 REGULATORY ANALYSIS 111 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 7.1.3 INDUSTRY STANDARDS 113 7.2 SUSTAINABILITY INITIATIVES 114 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR POULTRY DIAGNOSTIC PRODUCTS 114 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 114 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 115 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 116 8.1 KEY STAKEHOLDERS & BUYING CRITERIA 116 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 116 8.1.2 BUYING CRITERIA 117 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 118 8.2.1 DECISION-MAKING PROCESS 118 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 118 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 119 8.2.4 MARKET PROFITABILITY 120   9 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE 121 9.1 INTRODUCTION 122 9.2 CONSUMABLES & REAGENTS 124 9.2.1 ELISA KITS & REAGENTS 127 9.2.1.1 Large-scale serological surveillance and vaccination monitoring to sustain demand 127 9.2.1.2 Global volume analysis of ELISA kits & reagents, 2024–2031 (thousand units) 129 9.2.2 PCR KITS & REAGENTS 129 9.2.2.1 Rising adoption of molecular diagnostics to accelerate demand 129 9.2.2.2 Global volume analysis of PCR kits & reagents, 2024–2031 (thousand units) 132 9.2.3 SAMPLE PREPARATION & EXTRACTION KITS 132 9.2.3.1 Increasing use of molecular testing to fuel market growth 132 9.2.3.2 Global volume analysis of sample preparation & extraction kits, 2024–2031 (thousand units) 134 9.2.4 CONTROLS & LABORATORY CONSUMABLES 135 9.2.4.1 Expanding diagnostic test volumes to drive consistent demand 135 9.2.4.2 Global volume analysis of controls & laboratory consumables, 2024–2031 (thousand units) 137 9.3 INSTRUMENTS 137 9.3.1 PCR INSTRUMENTS 140 9.3.1.1 Growing need for rapid and high-sensitivity pathogen detection to boost market 140 9.3.1.2 Global volume analysis of PCR instruments, 2024–2031 (thousand units) 142 9.3.2 ELISA READERS & WASHERS 142 9.3.2.1 High-throughput serological testing to support continued use of ELISA readers 142 9.3.2.2 Global volume analysis of ELISA readers & washers, 2024–2031 (thousand units) 144 9.3.3 NUCLEIC ACID EXTRACTION SYSTEMS 144 9.3.3.1 Rising molecular testing workflows to drive adoption 144 9.3.3.2 Global volume analysis of nucleic acid extraction systems, 2024–2031 (thousand units) 146 9.3.4 OTHER LABORATORY AUTOMATION INSTRUMENTS 147 9.3.4.1 Global volume analysis of other laboratory automation instruments, 2024–2031 (thousand units) 148 10 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE 149 10.1 INTRODUCTION 150 10.2 PCR-BASED DIAGNOSTICS 151 10.2.1 AVIAN INFLUENZA PCR PANELS 154 10.2.1.1 Global surveillance programs and outbreak monitoring to boost demand 154 10.2.1.2 Global volume analysis of avian influenza PCR panels, 2024–2031 (thousand tests) 156 10.2.1.3 Global volume analysis of avian influenza PCR panels, 2024–2031 (thousand animals) 157 10.2.2 NEWCASTLE DISEASE PCR PANELS 157 10.2.2.1 High transmissibility of Newcastle disease to increase reliance on molecular PCR detection 157 10.2.2.2 Global volume analysis of Newcastle disease PCR panels, 2024–2031 (thousand tests) 159 10.2.2.3 Global volume analysis of Newcastle disease PCR panels, 2024–2031 (thousand animals) 160 10.2.3 ENDEMIC VIRAL PCR PANELS 160 10.2.3.1 Routine flock health monitoring to accelerate use of multiplex endemic viral PCR panels 160 10.2.3.2 Global volume analysis of endemic viral PCR panels, 2024–2031 (thousand tests) 162 10.2.3.3 Global volume analysis of endemic viral PCR panels, 2024–2031 (thousand animals) 163 10.2.4 MYCOPLASMA PCR PANELS 163 10.2.4.1 Need for early identification of mycoplasma infections to drive adoption 163 10.2.4.2 Global volume analysis of Mycoplasma PCR panels, 2024–2031 (thousand tests) 166 10.2.4.3 Global volume analysis of Mycoplasma PCR panels, 2024–2031 (thousand animals) 166 10.2.5 BACTERIAL PCR PANELS 167 10.2.5.1 Increasing focus on pathogen detection and food safety to support market growth 167 10.2.5.2 Global volume analysis of bacterial PCR panels, 2024–2031 (thousand tests) 169 10.2.5.3 Global volume analysis of bacterial PCR panels, 2024–2031 (thousand animals) 169 10.3 ELISA-BASED DIAGNOSTICS 170 10.3.1 ENDEMIC VIRAL ELISA TESTS 173 10.3.1.1 Routine immunity monitoring in poultry flocks to drive demand 173 10.3.1.2 Global volume analysis of endemic viral ELISA tests, 2024–2031 (thousand tests) 175 10.3.1.3 Global volume analysis of endemic viral ELISA tests, 2024–2031 (thousand animals) 175 10.3.2 AVIAN INFLUENZA ELISA TESTS 176 10.3.2.1 Large-scale serological surveillance programs to support use of avian influenza ELISA assays 176 10.3.2.2 Global volume analysis of avian influenza ELISA tests, 2024–2031 (thousand tests) 178 10.3.2.3 Global volume analysis of avian influenza ELISA tests, 2024–2031 (thousand animals) 178   10.3.3 NEWCASTLE DISEASE ELISA TESTS 179 10.3.3.1 Vaccination monitoring and flock immunity assessment to fuel demand 179 10.3.3.2 Global volume analysis of Newcastle disease ELISA tests, 2024–2031 (thousand tests) 181 10.3.3.3 Global volume analysis of Newcastle disease ELISA tests, 2024–2031 (thousand animals) 181 10.3.4 MYCOPLASMA ELISA TESTS 182 10.3.4.1 Ongoing flock health surveillance to increase adoption of mycoplasma ELISA testing 182 10.3.4.2 Global volume analysis of mycoplasma ELISA tests, 2024–2031 (thousand tests) 184 10.3.4.3 Global volume analysis of mycoplasma ELISA tests, 2024–2031 (thousand animals) 184 10.3.5 BACTERIAL ELISA TESTS 185 10.3.5.1 Growing emphasis on bacterial disease control to support use of bacterial ELISA diagnostics 185 10.3.5.2 Global volume analysis of bacterial ELISA tests, 2024–2031 (thousand tests) 187 10.3.5.3 Global volume analysis of bacterial ELISA tests, 2024–2031 (thousand animals) 187 10.4 OTHER DIAGNOSTIC TESTS 188 11 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE 190 11.1 INTRODUCTION 191 11.2 AVIAN INFLUENZA 191 11.2.1 GLOBAL SURVEILLANCE PROGRAMS AND FREQUENT HPAI OUTBREAKS TO DRIVE DEMAND 191 11.3 NEWCASTLE DISEASE 194 11.3.1 HIGH CONTAGIOUSNESS AND ONGOING OUTBREAK RISKS TO FUEL MARKET GROWTH 194 11.4 INFECTIOUS BRONCHITIS 196 11.4.1 EMERGENCE OF MULTIPLE IBV VARIANTS TO INCREASE DEMAND FOR DIAGNOSTICS 196 11.5 AVIAN MYCOPLASMOSIS 198 11.5.1 RISING FOCUS ON RESPIRATORY DISEASE CONTROL TO BOOST ADOPTION 198 11.6 SALMONELLOSIS 200 11.6.1 INCREASING FOOD SAFETY REGULATIONS AND SURVEILLANCE PROGRAMS TO BOOST MARKET GROWTH 200 11.7 INFECTIOUS BURSAL DISEASE 203 11.7.1 NEED TO MONITOR IMMUNOSUPPRESSIVE VIRAL INFECTIONS TO DRIVE DEMAND 203 11.8 OTHER INFECTIOUS DISEASES 205   12 POULTRY DIAGNOSTICS MARKET, BY POULTRY TYPE 208 12.1 INTRODUCTION 209 12.2 PCR-BASED DIAGNOSTICS 209 12.2.1 BROILERS 210 12.2.1.1 High-density meat production systems to drive strong adoption of PCR testing 210 12.2.2 LAYERS 212 12.2.2.1 Need for rapid detection of diseases affecting egg production to support market growth 212 12.2.3 BREEDERS 213 12.2.3.1 Prevention of vertical pathogen transmission to drive extensive PCR surveillance 213 12.2.4 TURKEYS 215 12.2.4.1 Disease monitoring in commercial turkey production to support adoption 215 12.2.5 DUCKS & GEESE 216 12.2.5.1 Role of waterfowl in avian influenza surveillance to increase PCR testing 216 12.2.6 OTHER POULTRY 218 12.3 ELISA-BASED DIAGNOSTICS 219 12.3.1 BROILERS 220 12.3.1.1 Monitoring vaccine-induced immunity to drive ELISA-based serological testing 220 12.3.2 LAYERS 222 12.3.2.1 Long production cycles and egg yield monitoring to support market growth 222 12.3.3 BREEDERS 223 12.3.3.1 Routine antibody monitoring for disease-free breeding programs to drive ELISA testing 223 12.3.4 TURKEYS 225 12.3.4.1 Need for effective vaccination monitoring to support ELISA-based diagnostics 225 12.3.5 DUCKS & GEESE 226 12.3.5.1 Serological surveillance of waterfowl populations to boost market growth 226 12.3.6 OTHER POULTRY 228 12.4 OTHER DIAGNOSTIC TESTS 229 12.4.1 BROILERS 230 12.4.1.1 Rapid screening and confirmatory testing to require conventional diagnostics 230 12.4.2 LAYERS 232 12.4.2.1 Long-term flock monitoring to drive continued use of traditional diagnostic tests 232   12.4.3 BREEDERS 233 12.4.3.1 Established serological methods to support disease surveillance in breeder flocks 233 12.4.4 TURKEYS 235 12.4.4.1 Routine disease screening and pathogen identification to sustain use of conventional diagnostics 235 12.4.5 DUCKS & GEESE 236 12.4.5.1 Surveillance of waterfowl-associated pathogens to maintain use of traditional diagnostic methods 236 12.4.6 OTHER POULTRY 238 13 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE 240 13.1 INTRODUCTION 241 13.2 SWABS 241 13.2.1 EASE OF COLLECTION AND SUITABILITY FOR MOLECULAR TESTING TO DRIVE WIDESPREAD USE OF SWAB SAMPLES 241 13.3 SERUM/BLOOD 243 13.3.1 GROWING FOCUS ON FLOCK IMMUNITY MONITORING AND VACCINATION ASSESSMENT TO SUPPORT DEMAND 243 13.4 TISSUE SAMPLES 244 13.4.1 NEED FOR CONFIRMATORY DIAGNOSIS AND DETAILED PATHOLOGICAL INVESTIGATION TO DRIVE MARKET GROWTH 244 13.5 ENVIRONMENTAL & FECAL SAMPLES 246 13.5.1 RISING EMPHASIS ON FARM-LEVEL SURVEILLANCE AND BIOSECURITY MONITORING TO BOOST ADOPTION 246 14 POULTRY DIAGNOSTICS MARKET, BY END USER 248 14.1 INTRODUCTION 249 14.2 VETERINARY DIAGNOSTIC LABORATORIES 249 14.2.1 CENTRAL ROLE IN DISEASE SURVEILLANCE AND HIGH TESTING VOLUMES TO DRIVE DEMAND 249 14.3 INTEGRATED POULTRY PRODUCERS 251 14.3.1 GROWING VERTICAL INTEGRATION AND NEED FOR CONTINUOUS FLOCK MONITORING TO INCREASE DIAGNOSTIC ADOPTION 251 14.4 GOVERNMENT & REFERENCE LABORATORIES 253 14.4.1 NATIONAL DISEASE SURVEILLANCE PROGRAMS AND REGULATORY TESTING REQUIREMENTS TO BOOST MARKET GROWTH 253 14.5 ACADEMIC & RESEARCH INSTITUTIONS 254 14.5.1 RISING RESEARCH ON POULTRY PATHOGENS AND DIAGNOSTIC INNOVATION TO SUPPORT DEMAND 254 14.6 OTHER SPECIALIZED LABORATORIES 256 14.6.1 INCREASING OUTSOURCING OF ADVANCED TESTING SERVICES TO DRIVE DEMAND 256   15 POULTRY DIAGNOSTICS MARKET, BY REGION 258 15.1 INTRODUCTION 259 15.2 NORTH AMERICA 260 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 261 15.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 262 15.2.3 NORTH AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 263 15.2.4 US 270 15.2.4.1 Large-scale poultry production to drive demand for poultry diagnostic testing 270 15.2.5 CANADA 277 15.2.5.1 Strong biosecurity regulations and expanding poultry production to drive market 277 15.3 EUROPE 284 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 284 15.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 285 15.3.3 EUROPE: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 286 15.3.4 GERMANY 293 15.3.4.1 Germany to dominate European market during forecast period 293 15.3.5 UK 299 15.3.5.1 Robust disease surveillance programs to drive market growth 299 15.3.6 FRANCE 305 15.3.6.1 Frequent avian influenza outbreaks and large poultry production systems to fuels market growth 305 15.3.7 ITALY 311 15.3.7.1 Growing poultry production to support market growth 311 15.3.8 SPAIN 317 15.3.8.1 Expanding broiler production and increasing disease surveillance to drive market growth 317 15.3.9 NETHERLANDS 323 15.3.9.1 Advanced veterinary surveillance infrastructure to drive market growth 323 15.3.10 POLAND 330 15.3.10.1 Rapid expansion of poultry production and export-oriented farming to increase demand 330 15.3.11 RUSSIA 336 15.3.11.1 Expanding domestic poultry production to drive market growth 336 15.3.12 REST OF EUROPE 342 15.4 ASIA PACIFIC 348 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 348 15.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 350 15.4.3 ASIA PACIFIC: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 351 15.4.4 CHINA 359 15.4.4.1 China to dominate APAC market during forecast period 359 15.4.5 JAPAN 365 15.4.5.1 Recurring avian influenza outbreaks to drive market 365 15.4.6 INDIA 371 15.4.6.1 Rapidly expanding poultry industry and increasing disease surveillance initiatives to boost market growth 371 15.4.7 AUSTRALIA 377 15.4.7.1 Strong biosecurity regulations and advanced poultry production systems to support market growth 377 15.4.8 SOUTH KOREA 383 15.4.8.1 Frequent avian influenza outbreaks and intensive poultry farming to boost market growth 383 15.4.9 THAILAND 389 15.4.9.1 Export-oriented poultry production to drive market 389 15.4.10 NEW ZEALAND 395 15.4.10.1 Strict biosecurity systems and preventive disease surveillance programs to support market growth 395 15.4.11 INDONESIA 401 15.4.11.1 Large poultry population to fuel market growth 401 15.4.12 PHILIPPINES 407 15.4.12.1 Expanding poultry production and rising disease monitoring efforts to drive adoption 407 15.4.13 REST OF ASIA PACIFIC 413 15.5 LATIN AMERICA 420 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 420 15.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 421 15.5.3 LATIN AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 422 15.5.4 BRAZIL 429 15.5.4.1 Large-scale poultry production and export-driven poultry industry to drive demand 429 15.5.5 MEXICO 435 15.5.5.1 Strong domestic poultry consumption to contribute to market growth 435 15.5.6 ARGENTINA 441 15.5.6.1 Expanding poultry production and increased disease monitoring to drive market 441 15.5.7 REST OF LATIN AMERICA 447 15.6 MIDDLE EAST & AFRICA 454 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 454 15.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 455 15.6.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031 456 15.6.4 GCC COUNTRIES 463 15.6.4.1 Kingdom of Saudi Arabia (KSA) 469 15.6.4.1.1 Expanding domestic poultry production and national food security initiatives to boost growth 469 15.6.4.2 United Arab Emirates (UAE) 475 15.6.4.2.1 Increasing investments in poultry farming to fuel UAE's market growth 475 15.6.4.3 Rest of GCC Countries 481 15.6.5 REST OF MIDDLE EAST & AFRICA 487 16 COMPETITIVE LANDSCAPE 494 16.1 OVERVIEW 494 16.2 KEY PLAYER STRATEGY/RIGHT TO WIN 494 16.3 REVENUE ANALYSIS, 2021−2025 496 16.4 MARKET SHARE ANALYSIS, 2025 497 16.4.1 US MARKET SHARE ANALYSIS, 2025 498 16.4.2 EUROPE MARKET SHARE ANALYSIS, 2025 499 16.4.3 RANKING OF KEY MARKET PLAYERS 500 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 502 16.5.1 STARS 502 16.5.2 EMERGING LEADERS 502 16.5.3 PERVASIVE PLAYERS 502 16.5.4 PARTICIPANTS 502 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 504 16.5.5.1 Company footprint 504 16.5.5.2 Region footprint 505 16.5.5.3 Product type footprint 506 16.5.5.4 Test type footprint 507 16.5.5.5 Disease type footprint 508 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 509 16.6.1 PROGRESSIVE COMPANIES 509 16.6.2 RESPONSIVE COMPANIES 509 16.6.3 DYNAMIC COMPANIES 509 16.6.4 STARTING BLOCKS 509 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 511 16.6.5.1 Detailed list of key startups/SMEs 511 16.6.5.2 Competitive benchmarking of key startups 512 16.7 BRAND/PRODUCT COMPARISON 513 16.8 R&D EXPENDITURE OF KEY PLAYERS 513 16.9 COMPANY VALUATION & FINANCIAL METRICS 514 16.9.1 FINANCIAL METRICS 514 16.9.2 COMPANY VALUATION 514 16.10 COMPETITIVE SCENARIO 515 16.10.1 PRODUCT LAUNCHES 515 16.10.2 DEALS 515 16.10.3 EXPANSIONS 516 16.10.4 OTHER DEVELOPMENTS 517 17 COMPANY PROFILES 518 17.1 KEY PLAYERS 518 17.1.1 IDEXX LABORATORIES, INC. 518 17.1.1.1 Business overview 518 17.1.1.2 Products offered 519 17.1.1.3 MnM view 521 17.1.1.3.1 Key strengths 521 17.1.1.3.2 Strategic choices 521 17.1.1.3.3 Weaknesses & competitive threats 521 17.1.2 THERMO FISHER SCIENTIFIC INC. 522 17.1.2.1 Business overview 522 17.1.2.2 Products offered 524 17.1.2.3 MnM view 525 17.1.2.3.1 Key strengths 525 17.1.2.3.2 Strategic choices 525 17.1.2.3.3 Weaknesses & competitive threats 525 17.1.3 ZOETIS SERVICES LLC 526 17.1.3.1 Business overview 526 17.1.3.2 Products offered 528 17.1.3.3 Recent developments 528 17.1.3.3.1 Deals 528 17.1.3.3.2 Expansions 529 17.1.3.3.3 Other developments 529 17.1.3.4 MnM view 530 17.1.3.4.1 Key strengths 530 17.1.3.4.2 Strategic choices 530 17.1.3.4.3 Weaknesses & competitive threats 530 17.1.4 BIOCHEK 531 17.1.4.1 Business overview 531 17.1.4.2 Products offered 531 17.1.4.3 Recent developments 533 17.1.4.3.1 Product launches 533 17.1.4.3.2 Deals 534 17.1.4.4 MnM view 534 17.1.4.4.1 Key strengths 534 17.1.4.4.2 Strategic choices 534 17.1.4.4.3 Weaknesses & competitive threats 535   17.1.5 INNOVATIVE DIAGNOSTICS 536 17.1.5.1 Business overview 536 17.1.5.2 Products offered 536 17.1.5.3 Recent developments 539 17.1.5.3.1 Other developments 539 17.1.5.4 MnM view 540 17.1.5.4.1 Key strengths 540 17.1.5.4.2 Strategic choices 540 17.1.5.4.3 Weaknesses & competitive threats 540 17.1.6 BIONOTE 541 17.1.6.1 Business overview 541 17.1.6.2 Products offered 541 17.1.6.3 Recent developments 542 17.1.6.3.1 Deals 542 17.1.7 BIO-RAD LABORATORIES, INC. 543 17.1.7.1 Business overview 543 17.1.7.2 Products offered 544 17.1.8 GD 545 17.1.8.1 Business overview 545 17.1.8.2 Products offered 545 17.1.8.3 Recent developments 548 17.1.8.3.1 Product launches 548 17.1.8.3.2 Deals 548 17.1.8.3.3 Expansions 548 17.1.8.3.4 Other developments 549 17.1.9 INDICAL BIOSCIENCE GMBH 550 17.1.9.1 Business overview 550 17.1.9.2 Products offered 551 17.1.9.3 Recent developments 552 17.1.9.3.1 Product enhancements 552 17.1.10 SHENZHEN BIOEASY BIOTECHNOLOGY, INC. 553 17.1.10.1 Business overview 553 17.1.10.2 Products offered 553 17.1.11 RING BIOTECHNOLOGY CO., LTD. 554 17.1.11.1 Business overview 554 17.1.11.2 Products offered 555 17.1.11.3 Recent developments 556 17.1.11.3.1 Product launches 556 17.1.12 BIO-X DIAGNOSTICS S.A. 557 17.1.12.1 Business overview 557 17.1.12.2 Products offered 557   17.1.13 MEGACOR DIAGNOSTIK GMBH 559 17.1.13.1 Business overview 559 17.1.13.2 Products offered 560 17.1.14 GOLD STANDARD DIAGNOSTICS 562 17.1.14.1 Business overview 562 17.1.14.2 Products offered 562 17.1.14.2.1 Other developments 564 17.1.15 BIONEER CORPORATION 565 17.1.15.1 Business overview 565 17.1.15.2 Products offered 566 17.2 OTHER PLAYERS 567 17.2.1 ELABSCIENCE, INC. 567 17.2.2 BIOSELLAL 568 17.2.3 BIOGAL 569 17.2.4 BIOSTONE ANIMAL HEALTH 570 17.2.5 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD. 574 17.2.6 ABBEXA 575 17.2.7 BIOINGENTECH 576 17.2.8 AFFIGEN INC. 579 17.2.9 ALVEO TECHNOLOGIES 580 17.2.10 HIMEDIA LABORATORIES 581 18 RESEARCH METHODOLOGY 582 18.1 RESEARCH DATA 582 18.2 RESEARCH METHODOLOGY DESIGN 582 18.2.1 SECONDARY DATA 583 18.2.1.1 Key data from secondary sources 584 18.2.2 PRIMARY DATA 584 18.2.2.1 Key data from primary sources 585 18.2.2.2 Key industry insights 586 18.3 MARKET SIZE ESTIMATION 587 18.3.1 BOTTOM-UP APPROACH 595 18.4 MARKET BREAKDOWN & DATA TRIANGULATION 596 18.5 MARKET SHARE ANALYSIS 597 18.5.1 RESEARCH ASSUMPTIONS 597 18.5.2 GROWTH RATE ASSUMPTIONS 597 18.6 RISK ASSESSMENT 598 18.7 RESEARCH LIMITATIONS 598 18.7.1 METHODOLOGY-RELATED LIMITATIONS 598 18.7.2 SCOPE-RELATED LIMITATIONS 598   19 APPENDIX 599 19.1 DISCUSSION GUIDE 599 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 605 19.3 CUSTOMIZATION OPTIONS 607 19.3.1 PRODUCT ANALYSIS 607 19.3.2 COMPANY INFORMATION 607 19.3.3 GEOGRAPHIC ANALYSIS 607 19.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 607 19.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE 607 19.3.6 MARKET SHARE ANALYSIS, BY PRODUCT TYPE (TOP 5 PLAYERS) 607 19.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 607 19.4 RELATED REPORTS 608 19.5 AUTHOR DETAILS 609
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 52 TABLE 2 POULTRY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 75 TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 78 TABLE 4 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 84 TABLE 5 AVERAGE SELLING PRICE TREND OF ELISA KITS & REAGENTS, BY REGION, 2023−2025 86 TABLE 6 AVERAGE SELLING PRICE TREND OF PCR REAGENTS & KITS, BY REGION, 2023−2025 86 TABLE 7 AVERAGE SELLING PRICE TREND OF SAMPLE PREPARATION & EXTRACTION KITS, BY REGION, 2023−2025 86 TABLE 8 AVERAGE SELLING PRICE TREND OF CONTROLS & LABORATORY CONSUMABLES, BY REGION, 2023−2025 87 TABLE 9 AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2023−2025 87 TABLE 10 AVERAGE SELLING PRICE TREND OF ELISA READERS & WASHERS, BY REGION, 2023−2025 87 TABLE 11 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID EXTRACTION SYSTEMS, BY REGION, 2023−2025 88 TABLE 12 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 89 TABLE 13 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 89 TABLE 14 POULTRY DIAGNOSTICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027 90 TABLE 15 CASE STUDY 1: AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 92 TABLE 16 CASE STUDY 2: MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR 93 TABLE 17 CASE STUDY 3: MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS 94 TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES 96 TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR POULTRY DIAGNOSTIC PRODUCTS 96 TABLE 20 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 97 TABLE 21 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 97 TABLE 22 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 98 TABLE 23 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 98 TABLE 24 POULTRY DIAGNOSTICS MARKET: MAJOR PATENTS 106 TABLE 25 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET 110 TABLE 26 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 27 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 28 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 29 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY DIAGNOSTIC PRODUCTS 116 TABLE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 117 TABLE 31 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 122 TABLE 32 POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 33 KEY PLAYERS PROVIDING CONSUMABLES & REAGENTS 124 TABLE 34 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 125 TABLE 35 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 36 KEY PLAYERS PROVIDING ELISA KITS & REAGENTS 127 TABLE 37 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 38 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 129 TABLE 39 KEY PLAYERS PROVIDING PCR KITS & REAGENTS 130 TABLE 40 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 41 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 132 TABLE 42 KEY PLAYERS PROVIDING SAMPLE PREPARATION & EXTRACTION KITS 133 TABLE 43 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 44 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY TYPE, 2024–2031 (THOUSAND UNITS) 134 TABLE 45 KEY PLAYERS PROVIDING CONTROLS & LABORATORY CONSUMABLES 135 TABLE 46 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 47 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY TYPE, 2024–2031 (THOUSAND UNITS) 137 TABLE 48 KEY PLAYERS PROVIDING INSTRUMENTS 138 TABLE 49 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 50 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 51 KEY PLAYERS PROVIDING PCR INSTRUMENTS 140 TABLE 52 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 53 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 142 TABLE 54 KEY PLAYERS PROVIDING ELISA READERS & WASHERS 143 TABLE 55 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 56 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS, BY TYPE, 2024–2031 (THOUSAND UNITS) 144 TABLE 57 KEY PLAYERS PROVIDING NUCLEIC ACID EXTRACTION SYSTEMS 145 TABLE 58 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 59 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS, BY TYPE, 2024–2031 (THOUSAND UNITS) 146 TABLE 60 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 61 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 148 TABLE 62 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 150 TABLE 63 KEY PLAYERS PROVIDING PCR-BASED DIAGNOSTICS 151 TABLE 64 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 153 TABLE 65 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 66 KEY PLAYERS PROVIDING AVIAN INFLUENZA PCR PANELS 155 TABLE 67 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 68 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY TYPE, 2024–2031 (THOUSAND TESTS) 156 TABLE 69 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 157 TABLE 70 KEY PLAYERS PROVIDING NEWCASTLE DISEASE PCR PANELS 158 TABLE 71 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 72 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY TYPE, 2024–2031 (THOUSAND TESTS) 159 TABLE 73 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 160 TABLE 74 KEY PLAYERS PROVIDING ENDEMIC VIRAL PCR PANELS 161 TABLE 75 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 76 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY TYPE, 2024–2031 (THOUSAND TESTS) 162 TABLE 77 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 163 TABLE 78 KEY PLAYERS PROVIDING MYCOPLASMA PCR PANELS 164 TABLE 79 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 80 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY TYPE, 2024–2031 (THOUSAND TESTS) 166 TABLE 81 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 166 TABLE 82 KEY PLAYERS PROVIDING BACTERIAL PCR PANELS 167 TABLE 83 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 84 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY TYPE, 2024–2031 (THOUSAND TESTS) 169 TABLE 85 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 169 TABLE 86 KEY PLAYERS PROVIDING ELISA-BASED DIAGNOSTICS 170 TABLE 87 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 88 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 89 KEY PLAYERS PROVIDING ENDEMIC VIRAL ELISA TESTS 173 TABLE 90 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 91 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND TESTS) 175 TABLE 92 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 175 TABLE 93 KEY PLAYERS PROVIDING AVIAN INFLUENZA ELISA TESTS 176 TABLE 94 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 95 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND TESTS) 178 TABLE 96 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 178 TABLE 97 KEY PLAYERS PROVIDING NEWCASTLE DISEASE ELISA TESTS 179 TABLE 98 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 99 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND TESTS) 181 TABLE 100 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 181 TABLE 101 KEY PLAYERS PROVIDING MYCOPLASMA ELISA TESTS 182 TABLE 102 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 103 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND TESTS) 184 TABLE 104 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 184 TABLE 105 KEY PLAYERS PROVIDING BACTERIAL ELISA TESTS 185 TABLE 106 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 107 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND TESTS) 187 TABLE 108 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 187 TABLE 109 KEY PLAYERS PROVIDING OTHER DIAGNOSTIC TESTS 188 TABLE 110 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 111 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 191 TABLE 112 KEY PLAYERS PROVIDING AVIAN INFLUENZA DIAGNOSTIC PRODUCTS 192 TABLE 113 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 114 KEY PLAYERS PROVIDING NEWCASTLE DISEASE DIAGNOSTIC PRODUCTS 194 TABLE 115 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 116 KEY PLAYERS PROVIDING INFECTIOUS BRONCHITIS DIAGNOSTIC PRODUCTS 197 TABLE 117 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BRONCHITIS, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 118 KEY PLAYERS PROVIDING AVIAN MYCOPLASMOSIS DIAGNOSTIC PRODUCTS 199 TABLE 119 POULTRY DIAGNOSTICS MARKET FOR AVIAN MYCOPLASMOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 120 KEY PLAYERS PROVIDING SALMONELLOSIS DIAGNOSTIC PRODUCTS 201 TABLE 121 POULTRY DIAGNOSTICS MARKET FOR SALMONELLOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 122 KEY PLAYERS PROVIDING INFECTIOUS BURSAL DISEASE DIAGNOSTIC PRODUCTS 204 TABLE 123 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BURSAL DISEASE, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 124 KEY PLAYERS PROVIDING OTHER INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 206 TABLE 125 POULTRY DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 126 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 210 TABLE 127 PCR-BASED DIAGNOSTICS MARKET FOR BROILERS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 128 PCR-BASED DIAGNOSTICS MARKET FOR LAYERS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 129 PCR-BASED DIAGNOSTICS MARKET FOR BREEDERS, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 130 PCR-BASED DIAGNOSTICS MARKET FOR TURKEYS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 131 PCR-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 132 PCR-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 133 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 220 TABLE 134 ELISA-BASED DIAGNOSTICS MARKET FOR BROILERS, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 135 ELISA-BASED DIAGNOSTICS MARKET FOR LAYERS, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 136 ELISA-BASED DIAGNOSTICS MARKET FOR BREEDERS, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 137 ELISA-BASED DIAGNOSTICS MARKET FOR TURKEYS, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 138 ELISA-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 139 ELISA-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 140 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 230 TABLE 141 OTHER DIAGNOSTIC TESTS MARKET FOR BROILERS, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 142 OTHER DIAGNOSTIC TESTS MARKET FOR LAYERS, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 143 OTHER DIAGNOSTIC TESTS MARKET FOR BREEDERS, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 144 OTHER DIAGNOSTIC TESTS MARKET FOR TURKEYS, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 145 OTHER DIAGNOSTIC TESTS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 146 OTHER DIAGNOSTIC TESTS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 147 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 241 TABLE 148 POULTRY DIAGNOSTICS MARKET FOR SWABS, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 149 POULTRY DIAGNOSTICS MARKET FOR SERUM/BLOOD, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 150 POULTRY DIAGNOSTICS MARKET FOR TISSUE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 151 POULTRY DIAGNOSTICS MARKET FOR ENVIRONMENTAL & FECAL SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 152 POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 249 TABLE 153 POULTRY DIAGNOSTICS MARKET FOR VETERINARY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 154 POULTRY DIAGNOSTICS MARKET FOR INTEGRATED POULTRY PRODUCERS, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 155 POULTRY DIAGNOSTICS MARKET FOR GOVERNMENT & REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 156 POULTRY DIAGNOSTICS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 157 POULTRY DIAGNOSTICS MARKET FOR OTHER SPECIALIZED LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 158 POULTRY DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 159 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 262 TABLE 160 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 262 TABLE 161 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 263 TABLE 162 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 263 TABLE 163 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 264 TABLE 164 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 264 TABLE 165 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 166 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 265 TABLE 167 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 168 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 169 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 266 TABLE 170 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 171 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 172 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 268 TABLE 173 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 268 TABLE 174 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 269 TABLE 175 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 269 TABLE 176 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 270 TABLE 177 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 270 TABLE 178 US: KEY MACROINDICATORS 271 TABLE 179 US: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 272 TABLE 180 US: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 181 US: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 182 US: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 273 TABLE 183 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 184 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 185 US: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 274 TABLE 186 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 275 TABLE 187 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 275 TABLE 188 US: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 276 TABLE 189 US: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 276 TABLE 190 US: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 277 TABLE 191 CANADA: KEY MACROINDICATORS 278 TABLE 192 CANADA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 278 TABLE 193 CANADA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 194 CANADA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 195 CANADA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 279 TABLE 196 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 197 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 198 CANADA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 281 TABLE 199 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 281 TABLE 200 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 282 TABLE 201 CANADA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 282 TABLE 202 CANADA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 283 TABLE 203 CANADA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 204 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 285 TABLE 205 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 285 TABLE 206 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 286 TABLE 207 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 286 TABLE 208 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 287 TABLE 209 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 287 TABLE 210 EUROPE: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 211 EUROPE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 288 TABLE 212 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 213 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 214 EUROPE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 289 TABLE 215 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 216 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 217 EUROPE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 291 TABLE 218 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 291 TABLE 219 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 292 TABLE 220 EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 292 TABLE 221 EUROPE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 293 TABLE 222 EUROPE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2 024–2031 (USD MILLION) 293 TABLE 223 GERMANY: KEY MACROINDICATORS 294 TABLE 224 GERMANY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 294 TABLE 225 GERMANY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 226 GERMANY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 227 GERMANY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 295 TABLE 228 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 229 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 230 GERMANY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 297 TABLE 231 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 297 TABLE 232 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 298 TABLE 233 GERMANY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 298 TABLE 234 GERMANY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 299 TABLE 235 GERMANY: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 299 TABLE 236 UK: KEY MACROINDICATORS 300 TABLE 237 UK: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 300 TABLE 238 UK: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 239 UK: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 240 UK: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 301 TABLE 241 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 242 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 243 UK: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 303 TABLE 244 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 303 TABLE 245 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 304 TABLE 246 UK: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 304 TABLE 247 UK: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 305 TABLE 248 UK: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 305 TABLE 249 FRANCE: KEY MACROINDICATORS 306 TABLE 250 FRANCE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 306 TABLE 251 FRANCE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 252 FRANCE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 253 FRANCE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 307 TABLE 254 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 255 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 256 FRANCE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 309 TABLE 257 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 309 TABLE 258 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 310 TABLE 259 FRANCE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 310 TABLE 260 FRANCE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 311 TABLE 261 FRANCE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 311 TABLE 262 ITALY: KEY MACROINDICATORS 312 TABLE 263 ITALY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 312 TABLE 264 ITALY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 265 ITALY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 266 ITALY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 313 TABLE 267 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 268 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 269 ITALY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 315 TABLE 270 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 315 TABLE 271 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 316 TABLE 272 ITALY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 316 TABLE 273 ITALY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 317 TABLE 274 ITALY: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 317 TABLE 275 SPAIN: KEY MACROINDICATORS 318 TABLE 276 SPAIN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 318 TABLE 277 SPAIN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 278 SPAIN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 279 SPAIN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 319 TABLE 280 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 281 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 282 SPAIN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 321 TABLE 283 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 321 TABLE 284 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 322 TABLE 285 SPAIN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 322 TABLE 286 SPAIN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 323 TABLE 287 SPAIN: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 323 TABLE 288 NETHERLANDS: KEY MACROINDICATORS 324 TABLE 289 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 324 TABLE 290 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 291 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 292 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 326 TABLE 293 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 294 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 295 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 327 TABLE 296 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 328 TABLE 297 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 328 TABLE 298 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 329 TABLE 299 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 329 TABLE 300 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 330 TABLE 301 POLAND: KEY MACROINDICATORS 331 TABLE 302 POLAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 331 TABLE 303 POLAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 304 POLAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 305 POLAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 332 TABLE 306 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 307 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 308 POLAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 333 TABLE 309 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 334 TABLE 310 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 334 TABLE 311 POLAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 335 TABLE 312 POLAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 335 TABLE 313 POLAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 336 TABLE 314 RUSSIA: KEY MACROINDICATORS 337 TABLE 315 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 337 TABLE 316 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 317 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 318 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 338 TABLE 319 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 320 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 321 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 339 TABLE 322 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 340 TABLE 323 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 340 TABLE 324 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 341 TABLE 325 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 341 TABLE 326 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 342 TABLE 327 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 342 TABLE 328 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 329 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 330 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 343 TABLE 331 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 332 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 333 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 345 TABLE 334 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 345 TABLE 335 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 346 TABLE 336 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 346 TABLE 337 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 347 TABLE 338 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 347 TABLE 339 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 350 TABLE 340 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 350 TABLE 341 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 351 TABLE 342 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 351 TABLE 343 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 352 TABLE 344 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 352 TABLE 345 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 346 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 353 TABLE 347 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 348 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 349 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 354 TABLE 350 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 351 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 352 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 356 TABLE 353 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 356 TABLE 354 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 357 TABLE 355 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 357 TABLE 356 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 358 TABLE 357 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 358 TABLE 358 CHINA: KEY MACROINDICATORS 359 TABLE 359 CHINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 360 TABLE 360 CHINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 361 CHINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 362 CHINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 361 TABLE 363 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 364 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 365 CHINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 362 TABLE 366 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 363 TABLE 367 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 363 TABLE 368 CHINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 364 TABLE 369 CHINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 364 TABLE 370 CHINA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 365 TABLE 371 JAPAN: KEY MACROINDICATORS 366 TABLE 372 JAPAN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 366 TABLE 373 JAPAN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 374 JAPAN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 375 JAPAN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 367 TABLE 376 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 377 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 378 JAPAN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 369 TABLE 379 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 369 TABLE 380 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 370 TABLE 381 JAPAN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 370 TABLE 382 JAPAN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 371 TABLE 383 JAPAN: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 371 TABLE 384 INDIA: KEY MACROINDICATORS 372 TABLE 385 INDIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 372 TABLE 386 INDIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 387 INDIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 388 INDIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 373 TABLE 389 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 390 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 391 INDIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 375 TABLE 392 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 375 TABLE 393 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 376 TABLE 394 INDIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 376 TABLE 395 INDIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 377 TABLE 396 INDIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 377 TABLE 397 AUSTRALIA: KEY MACROINDICATORS 378 TABLE 398 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 378 TABLE 399 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 400 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 401 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 379 TABLE 402 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 403 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 404 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 381 TABLE 405 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 381 TABLE 406 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 382 TABLE 407 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 382 TABLE 408 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 383 TABLE 409 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 383 TABLE 410 SOUTH KOREA: KEY MACROINDICATORS 384 TABLE 411 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 384 TABLE 412 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 413 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 414 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 385 TABLE 415 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 416 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 417 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 387 TABLE 418 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 387 TABLE 419 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 388 TABLE 420 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 388 TABLE 421 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 389 TABLE 422 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 389 TABLE 423 THAILAND: KEY MACROINDICATORS 390 TABLE 424 THAILAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 390 TABLE 425 THAILAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 426 THAILAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 427 THAILAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 391 TABLE 428 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 429 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 430 THAILAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 393 TABLE 431 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 393 TABLE 432 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 394 TABLE 433 THAILAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 394 TABLE 434 THAILAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 395 TABLE 435 THAILAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 395 TABLE 436 NEW ZEALAND: KEY MACROINDICATORS 396 TABLE 437 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 396 TABLE 438 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 439 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 440 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 397 TABLE 441 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 442 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 443 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 399 TABLE 444 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 399 TABLE 445 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 400 TABLE 446 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 400 TABLE 447 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 401 TABLE 448 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 401 TABLE 449 INDONESIA: KEY MACROINDICATORS 402 TABLE 450 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 402 TABLE 451 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 452 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 453 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 403 TABLE 454 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 455 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 456 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 405 TABLE 457 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 405 TABLE 458 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 406 TABLE 459 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 406 TABLE 460 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 407 TABLE 461 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 407 TABLE 462 PHILIPPINES: KEY MACROINDICATORS 408 TABLE 463 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 408 TABLE 464 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 465 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 466 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 409 TABLE 467 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 468 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 469 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 411 TABLE 470 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 411 TABLE 471 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 412 TABLE 472 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 412 TABLE 473 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 413 TABLE 474 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 413 TABLE 475 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 414 TABLE 476 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 477 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 478 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 415 TABLE 479 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 480 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 481 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 417 TABLE 482 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 417 TABLE 483 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 418 TABLE 484 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 418 TABLE 485 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 419 TABLE 486 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 419 TABLE 487 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 421 TABLE 488 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 421 TABLE 489 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 422 TABLE 490 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 422 TABLE 491 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 423 TABLE 492 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 423 TABLE 493 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 424 TABLE 494 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 424 TABLE 495 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 496 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 497 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 425 TABLE 498 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 499 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 500 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 427 TABLE 501 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 427 TABLE 502 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 428 TABLE 503 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 428 TABLE 504 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 429 TABLE 505 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 429 TABLE 506 BRAZIL: KEY MACROINDICATORS 430 TABLE 507 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 430 TABLE 508 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 509 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 510 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 431 TABLE 511 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 512 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 513 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 433 TABLE 514 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 433 TABLE 515 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 434 TABLE 516 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 434 TABLE 517 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 435 TABLE 518 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 435 TABLE 519 MEXICO: KEY MACROINDICATORS 436 TABLE 520 MEXICO: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 436 TABLE 521 MEXICO: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 522 MEXICO: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 523 MEXICO: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 437 TABLE 524 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 525 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 526 MEXICO: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 439 TABLE 527 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 439 TABLE 528 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 440 TABLE 529 MEXICO: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 440 TABLE 530 MEXICO: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 441 TABLE 531 MEXICO: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 441 TABLE 532 ARGENTINA: KEY MACROINDICATORS 442 TABLE 533 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 442 TABLE 534 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 535 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 536 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 443 TABLE 537 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 538 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 539 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 445 TABLE 540 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 445 TABLE 541 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 446 TABLE 542 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 446 TABLE 543 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 447 TABLE 544 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 447 TABLE 545 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 448 TABLE 546 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 547 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 548 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 449 TABLE 549 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 550 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 551 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 451 TABLE 552 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 451 TABLE 553 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 452 TABLE 554 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 452 TABLE 555 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 453 TABLE 556 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 453 TABLE 557 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 455 TABLE 558 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 455 TABLE 559 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 456 TABLE 560 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 456 TABLE 561 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND TESTS) 457 TABLE 562 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (THOUSAND ANIMALS) 457 TABLE 563 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 458 TABLE 564 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 458 TABLE 565 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 566 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 567 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 459 TABLE 568 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 569 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 570 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 461 TABLE 571 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 461 TABLE 572 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 462 TABLE 573 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 462 TABLE 574 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 463 TABLE 575 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 463 TABLE 576 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 464 TABLE 577 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 464 TABLE 578 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 579 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 580 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 465 TABLE 581 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 582 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 583 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 467 TABLE 584 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 467 TABLE 585 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 468 TABLE 586 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 468 TABLE 587 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 469 TABLE 588 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 589 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 470 TABLE 590 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 470 TABLE 591 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 592 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 593 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 471 TABLE 594 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 595 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 596 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 473 TABLE 597 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 473 TABLE 598 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 474 TABLE 599 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 474 TABLE 600 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 475 TABLE 601 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 475 TABLE 602 UNITED ARAB EMIRATES: KEY MACROINDICATORS 476 TABLE 603 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 476 TABLE 604 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 605 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 606 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 477 TABLE 607 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 608 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 609 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 479 TABLE 610 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 479 TABLE 611 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 480 TABLE 612 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 480 TABLE 613 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 481 TABLE 614 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 481 TABLE 615 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 482 TABLE 616 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 617 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 618 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 483 TABLE 619 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 620 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 621 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 485 TABLE 622 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 485 TABLE 623 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 486 TABLE 624 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 486 TABLE 625 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 487 TABLE 626 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 487 TABLE 627 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 488 TABLE 628 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 629 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 630 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 489 TABLE 631 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 632 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 633 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024–2031 (USD MILLION) 491 TABLE 634 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 491 TABLE 635 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 492 TABLE 636 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024–2031 (USD MILLION) 492 TABLE 637 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION) 493 TABLE 638 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 493 TABLE 639 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET 494 TABLE 640 POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 498 TABLE 641 US POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 499 TABLE 642 EUROPE POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 500 TABLE 643 POULTRY DIAGNOSTICS MARKET: REGION FOOTPRINT 505 TABLE 644 POULTRY DIAGNOSTICS MARKET: PRODUCT TYPE FOOTPRINT 506 TABLE 645 POULTRY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT 507 TABLE 646 POULTRY DIAGNOSTICS MARKET: DISEASE TYPE FOOTPRINT 508 TABLE 647 POULTRY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 511 TABLE 648 POULTRY DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS 512 TABLE 649 POULTRY DIAGNOSTICS MARKET: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026 515 TABLE 650 POULTRY DIAGNOSTICS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026 515 TABLE 651 POULTRY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2026 516 TABLE 652 POULTRY DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026 517 TABLE 653 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 518 TABLE 654 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 519 TABLE 655 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 522 TABLE 656 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 524 TABLE 657 ZOETIS SERVICES LLC: COMPANY OVERVIEW 526 TABLE 658 ZOETIS SERVICES LLC: PRODUCTS OFFERED 528 TABLE 659 ZOETIS SERVICES LLC: DEALS, JANUARY 2022−FEBRUARY 2026 528 TABLE 660 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022−FEBRUARY 2026 529 TABLE 661 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 529 TABLE 662 BIOCHEK: COMPANY OVERVIEW 531 TABLE 663 BIOCHEK: PRODUCTS OFFERED 531 TABLE 664 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022−FEBRUARY 2026 533 TABLE 665 BIOCHEK: DEALS, JANUARY 2022–FEBRUARY 2026 534 TABLE 666 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 536 TABLE 667 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED 536 TABLE 668 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 539 TABLE 669 BIONOTE: COMPANY OVERVIEW 541 TABLE 670 BIONOTE: PRODUCTS OFFERED 541 TABLE 671 BIONOTE: DEALS, JANUARY 2022−FEBRUARY 2026 542 TABLE 672 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 543 TABLE 673 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 544 TABLE 674 GD: COMPANY OVERVIEW 545 TABLE 675 GD: PRODUCTS OFFERED 545 TABLE 676 GD: PRODUCT LAUNCHES, JANUARY 2022−FEBRUARY 2026 548 TABLE 677 GD: DEALS, JANUARY 2022−FEBRUARY 2026 548 TABLE 678 GD: EXPANSIONS, JANUARY 2022−FEBRUARY 2026 548 TABLE 679 GD: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 549 TABLE 680 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 550 TABLE 681 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED 551 TABLE 682 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022−FEBRUARY 2026 552 TABLE 683 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: COMPANY OVERVIEW 553 TABLE 684 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: PRODUCTS OFFERED 553 TABLE 685 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 554 TABLE 686 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 555 TABLE 687 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022−FEBRUARY 2026 556 TABLE 688 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW 557 TABLE 689 BIO-X DIAGNOSTICS S.A.: PRODUCTS OFFERED 557 TABLE 690 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW 559 TABLE 691 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED 560 TABLE 692 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 562 TABLE 693 GOLD STANDARD DIAGNOSTICS: PRODUCTS OFFERED 562 TABLE 694 GOLD STANDARD DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2026 564 TABLE 695 BIONEER CORPORATION: COMPANY OVERVIEW 565 TABLE 696 BIONEER CORPORATION: PRODUCTS OFFERED 566 TABLE 697 ELABSCIENCE, INC.: COMPANY OVERVIEW 567 TABLE 698 BIOSELLAL: COMPANY OVERVIEW 568 TABLE 699 BIOGAL: COMPANY OVERVIEW 569 TABLE 700 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW 570 TABLE 701 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW 574 TABLE 702 ABBEXA: COMPANY OVERVIEW 575 TABLE 703 BIOINGENTECH: COMPANY OVERVIEW 576 TABLE 704 AFFIGEN INC.: COMPANY OVERVIEW 579 TABLE 705 ALVEO TECHNOLOGIES: COMPANY OVERVIEW 580 TABLE 706 HIMEDIA LABORATORIES: COMPANY OVERVIEW 581 TABLE 707 RISK ASSESSMENT ANALYSIS 598 FIGURE 1 POULTRY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE 50 FIGURE 2 MARKET SCENARIO 55 FIGURE 3 GLOBAL POULTRY DIAGNOSTICS MARKET, 2024–2031 56 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2020–2025 56 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POULTRY DIAGNOSTICS MARKET 57 FIGURE 6 HIGH-GROWTH SEGMENTS IN POULTRY DIAGNOSTICS MARKET, 2026–2031 58 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POULTRY DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 59 FIGURE 8 INCREASING POULTRY DISEASE SURVEILLANCE TO FUEL MARKET GROWTH 60 FIGURE 9 CONSUMABLES & REAGENTS SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 61 FIGURE 10 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 62 FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 63 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 64 FIGURE 13 POULTRY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 FIGURE 14 POULTRY DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS 75 FIGURE 15 POULTRY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 80 FIGURE 16 POULTRY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 82 FIGURE 17 POULTRY DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS 83 FIGURE 18 AVERAGE SELLING PRICE OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2025 84 FIGURE 19 AVERAGE SELLING PRICE OF ELISA KITS AND REAGENTS AND PCR REAGENTS AND KITS, BY REGION, 2025 85 FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91 FIGURE 21 POULTRY DIAGNOSTICS MARKET: INVESTMENT & FUNDING SCENARIO 92 FIGURE 22 POULTRY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015–FEBRUARY 2026) 105 FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR POULTRY DIAGNOSTIC PATENTS (JANUARY 2015–FEBRUARY 2026) 106 FIGURE 24 AI USE CASES 109 FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY DIAGNOSTIC PRODUCTS 116 FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 117 FIGURE 27 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 259 FIGURE 28 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET SNAPSHOT 261 FIGURE 29 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET SNAPSHOT 349 FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2021−2025) 496 FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025) 497 FIGURE 32 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025) 498 FIGURE 33 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025) 499 FIGURE 34 RANKING OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2025 500 FIGURE 35 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 503 FIGURE 36 POULTRY DIAGNOSTICS MARKET: COMPANY FOOTPRINT 504 FIGURE 37 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 510 FIGURE 38 POULTRY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 513 FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2022−2025 513 FIGURE 40 EV/EBITDA OF KEY VENDORS 514 FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 514 FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 519 FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 523 FIGURE 44 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025) 527 FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 544 FIGURE 46 BIONEER CORPORATION: COMPANY SNAPSHOT (2025) 566 FIGURE 47 POULTRY DIAGNOSTICS MARKET: RESEARCH DESIGN 582 FIGURE 48 PRIMARY SOURCES 584 FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 586 FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 587 FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 587 FIGURE 52 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 588 FIGURE 53 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 588 FIGURE 54 REVENUE ANALYSIS OF TOP FIVE COMPANIES: POULTRY DIAGNOSTICS MARKET (2025) 589 FIGURE 55 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC CONSUMABLES & REAGENTS 590 FIGURE 56 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC INSTRUMENTS 592 FIGURE 57 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POULTRY DIAGNOSTICS MARKET (2026–2031) 593 FIGURE 58 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 593 FIGURE 59 TOP-DOWN APPROACH 594 FIGURE 60 BOTTOM-UP APPROACH 595 FIGURE 61 MARKET DATA TRIANGULATION METHODOLOGY 596

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們